IOL Chemicals & Pharmaceuticals Limited has announced the successful striking off of its wholly owned subsidiary, IOL Life Sciences Limited, from the Register of Companies. The Registrar of Companies, Ministry of Corporate Affairs, approved the application vide Notice No.STK-7/001115/2026 dated 1st April 2026.

Regulatory Compliance and Timeline

The company filed the application for striking off the subsidiary's name on 27th January 2026 under Section 248 of the Companies Act, 2013. This disclosure was made pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular dated 13th July 2023.

Financial Impact Assessment

The subsidiary's financial contribution to the parent company was minimal, as detailed in the regulatory disclosure:

Material Impact Statement

IOL Chemicals and Pharmaceuticals Limited has explicitly stated that the strike-off of IOL Life Sciences Limited does not have any material impact on the company's financials or operations. This assessment aligns with the subsidiary's negligible financial contribution to the parent company.

Regulatory Disclosure Requirements

The company has fulfilled all mandatory disclosure requirements under SEBI regulations, providing comprehensive details as required under SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023. The transaction does not fall within related party transactions and is not part of any scheme of arrangement.

The striking off represents a corporate housekeeping measure to streamline the company's subsidiary structure without affecting its core business operations or financial performance.

NCVI Enterprises Limited has made another significant acquisition in iol chemicals & pharmaceuticals Limited, acquiring an additional 4,04,305 equity shares through open market transactions on March 19, 2026. This follows the company's previous acquisition of 7,00,000 shares on March 18, 2026.

Latest Transaction Details

The recent acquisition was completed through open market purchases, with NCVI Enterprises acting as part of the promoter group in compliance with Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011.

Updated Shareholding Position

Following this latest acquisition, NCVI Enterprises' shareholding in IOL Chemicals and Pharmaceuticals Limited has increased further:

Recent Acquisition Timeline

NCVI Enterprises has been actively increasing its stake in IOL Chemicals through consecutive market purchases:

• March 18, 2026: Acquired 7,00,000 shares, increasing holding from 4,75,50,695 to 4,82,50,695 shares
• March 19, 2026: Acquired 4,04,305 shares, further increasing holding to 4,86,55,000 shares

Promoter Group Structure

The promoter group composition remains unchanged, with NCVI Enterprises Limited being part of a larger group that includes:

• Varinder Gupta: 59,79,325 shares
• Varinder Gupta (HUF): 5,500 shares
• Mayadevi Polycot Limited: 6,39,45,330 shares
• NM Merchantiles Limited: 5,01,31,650 shares
• NCVI Enterprises Limited: 4,86,55,000 shares (post-latest acquisition)

Company Overview

IOL Chemicals and Pharmaceuticals Limited maintains a total equity share capital of Rs. 58,70,55,020, comprising 29,35,27,510 equity shares of Rs. 2 each. The company's shares are listed on both the National Stock Exchange and BSE Limited.

The disclosure was signed by Abhiraj Gupta, Director (DIN: 08204917) of NCVI Enterprises Limited, confirming compliance with regulatory requirements. NCVI Enterprises Limited, formerly known as Towels Enterprises Ltd., operates from its registered office in Ludhiana and branch office in Barnala.